SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SynAct Pharma collaboration builds on ResoVir-2 development

Valid market news retained in the public archive without immediate LiveCast distribution.

AB

Related stories